p. 4 ABCA1 is to move phosphatidylserine from the internal to the external leaflet of the cell membrane and to mediate the release of phospholipid and cholesterol to lipid-free apolipoproteins that contain amphipathic α-helices, such as apolipoprotein A-I (apoA-I), the predominant apoprotein constituent of high density lipoproteins (HDL) [for review, (10) ]. The result of this ABCA1 activity is the generation of small nascent HDL particles with pre-β electrophoretic mobility. These lipid-poor HDL are subsequently converted to larger mature lipoproteins forms with α mobility through the action of plasma lecithin-cholesterol acyl-transferase which esterifies free cholesterol carried in the core of the lipoprotein (11) . HDL is felt to be important in reverse cholesterol transport, a process that results in the movement of cholesterol from peripheral cells to the liver. Many reports support the notion that HDL plays a critical role in the prevention of atherosclerosis, as the incidence of the disease is inversely proportional to the level of plasma HDL (11) . Impairment of ABCA1 function leads to Tangier disease in humans, characterized by a loss of circulating HDL, an accumulation of cholesterol in macrophages and premature atherosclerosis [for review, (12) ]. Gene-targeted disruption of ABCA1 in mice results in the virtual ablation of HDL and pathologic lesions in the lung. In these animals lacking ABCA1, there is an accumulation of cholesterol in alveolar macrophages and type II cells, alveolar proteinosis, and respiratory distress characterized by rapid, shallow breathing (13, 14) . These changes indicate the importance of ABCA1 function in this organ.
Recent studies examining the function of ABCA1 in primary cultures of type II pneumocytes or in a type II-like cell line have demonstrated a role for this transporter in type II cells and surfactant lipid turnover (7, 15) . The nuclear liver X receptor (LXR) agonist 22-hydroxycholesterol (22-OH) in combination with the retinoid X receptor (RXR) agonist 9-cis-retinoic acid (9cRA) have been shown to act on the promoter region of the ABCA1 gene [for review, (10) ]. The two agents were efficient in inducing ABCA1 mRNA expression and protein levels in type II cells, as has been found for many other cell types (7, 10, 15) . Incubation of stimulated type II cells with lipid-free apoA-I resulted in p. 5 the release of phospholipid and cholesterol, consistent with ABCA1 biologic activity (7) . ABCA1-mediated efflux of phospholipid from a mouse type II-like lung epithelial cell line (MLE-12) was shown to be basolateral, the surface that is in close contact with the pulmonary capillary system (15) .
Stimulation of phosphatidylcholine synthesis promoted ABCA1 phospholipid efflux in MLE-12 cells, while up-regulation of ABCA1 inhibited secretagogue-stimulated surfactant secretion from primary cultures of rat type II cells, evidence that supports an important role for this transporter in the regulation of alveolar surfactant homeostasis (7, 16) .
Type I pneumocytes act both as a barrier between the alveolar space and the pulmonary capillaries and as a regulator of alveolar fluid and ion homeostasis (17, 18) . Type I cells have been shown to exhibit Na + -K + -ATPase activity and express the epithelial Na + channel for active transalveolar ion transport, as well as aquaporin 5 for the regulation of water transport (17) (18) (19) . A characteristic feature of these cells is their many flask-shaped plasmalemmal invaginations, or caveolae, indicative of a possible role in alveolar protein transcytosis (20) . In addition, recent evidence has suggested that type I pneumocytes may be mechanosensors and indirectly regulate surfactant secretion by type II pneumocytes. In response to lung inflation, the type I cell increase in cytosolic calcium was transmitted to adjacent type II cells (21) and in co-cultures of pneumocytes subjected to mechanical stretch, the ATP released from type I cells provided a paracrine stimulation of surfactant secretion from the type II cells (22) . Gene expression profiling has suggested that type I cells also may play a role in lung development, protection from injury and host defense (23, 24) .
Given the extensive amount of type I cell plasma membrane and cholesterol-enriched caveolar invaginations, we hypothesized that the cholesterol turnover in type I cells is tightly regulated, and that ABCA1 should play an important role in this process. Using a cell culture system of type II cells stimulated to transdifferentiate toward a type I-like phenotype, we characterized the regulation of ABCA1 protein expression and function after exposure of the cells to LXR/RXR p. 6 agonists. We found ABCA1-mediated lipid export from the type I cell-like pneumocytes in the presence of lipid-free apoA-I, with the resultant production of particles in the HDL density range.
p. 7 Materials and Methods

Materials
The following were purchased from Sigma (St. Louis, MO): fetal bovine serum (FBS), gentamycin, rat immunoglobulin G (IgG), aprotinin, leupeptin, pepstatin, and phenylmethylsulfonyl fluoride (PMSF), dimethylsulphoxide (DMSO), 22-R-hydroxycholesterol (22-OH) and 9-cis-retinoic acid (9cRA). Organic solvents and scintillation fluid were purchased from Fisher Scientific (Pittsburgh, PA were purchased from CellGro (Herndon, VA). Fatty acid free bovine serum albumin (BSA) was from Intergen (Purchase, NY).
Antibodies
The rabbit polyclonal antibody made to a partial peptide sequence of human ABCA1 was purchased from Novus Biologicals (Littleton, CO). This antibody specifically recognizes a single 220 kDa ABCA1 protein in isolated epithelial cells cultured for 5 days with only minor amounts of other proteins visible and has been used for immunohistochemical purposes (25) . The polyclonal goat anti-mouse apolipoprotein A-I antibody was from US Biological (Swampscott, MA).
Monoclonal antibody VIIIB2 that recognizes an epitope in the plasma membrane of alveolar type I cells, and monoclonal antibody 3C9 that recognizes ABCA3 in type II cell lamellar bodies, have been described previously (26, 27) . Alexa-labeled secondary antibodies were from Molecular Probes (Eugene, OR). Anti-β-actin antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA).
Animals
p. 8 Pathogen-free Sprague-Dawley male rats (200 to 250 g) and C57/BL6 male mice (between 5-6 weeks of age and weighing 20 to 25 g) were obtained from Charles River (Wilmington, MA). All protocols adhered to the principles of the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Isolation and culture of alveolar epithelial cells.
For rat cells, intratracheal elastase (3 units/ml, Worthington, Inc, Lakewood, NJ) was instilled into the lungs of pathogen-free male Sprague-Dawley rats (300 g) as previously described (28, 29 (5, 31, 32) . This preparation will be referred to as type I-like cells hereafter, adopting the nomenclature of other investigators using similar culture systems (33, 34) .
Apolipoproteins
Lipid-free human apoA-I was isolated by anion-exchange chromatography on Q-Sepharose from delipidated human HDL as described previously (35) . ApoA-I was solubilized in 6 M guanidine-HCl overnight at 4 o C. This solution was extensively dialyzed against a buffer of 10 mM
Tris-HCl, 0.15 M NaCl, and 1 mM EDTA (disodium), filtered (0.45 µm Millipore), and stored at 4 o C. 14 C-radiolabeled apoA-I (specific activity of approx. 1µCi/mg) was produced by reductive methylation using 14 C-formaldehyde (36) . The procedure has no effect on apoA-I lipid binding properties or ability to form HDL particles (35, 36) . produced the maximum response without toxicity (as determined by lack of release of lactic dehydrogenase or lack of change in cell protein/dish with cells exposed to agonists as compared to controls without additions). Control cells were incubated in equivalent levels of BSA and diluent p. 10 with a final concentration of DMSO and ethanol of less than 0.03 %. Next, human apoA-I (10 µg/ml, 1 ml /plate) was added to the cells in MEM for an additional time as indicated. To terminate the experiment, the media were removed and centrifuged to pellet detached cells. For phospholipid efflux, methanol was added to the cell monolayers, and the cells were scraped from the dish. The cells and the media were extracted separately using chloroform:methanol:water (2:2:1.8, v/v) (37) with 500 µg egg phosphatidylcholine added as carrier. The 
Measurement of cholesterol and phospholipid release into media
Western analysis
Tissue and cellular extracts were lysed in buffer [0.5% NP-40, 10 mM Tris, 1 mM MgCl 2 , 1%
Triton X-100, pH 7.5] supplemented with protease inhibitors aprotinin (10 µg/ml), leupeptin (1 µg/ml), pepstatin (1 µg/ml), and PMSF (0. 
Sucrose density ultracentrifugation analysis
Pooled conditioned media from labeled cells were filtered through a 0.45 µm filter (Millex-HV, Millipore, Bedford, MA) and the density of the lipid-containing particles determined using a modification of the method of Hara and Yokoyama (38) . A sucrose solution of density = 1.1g/m p. 12 (9ml) was placed over a sucrose solution of d = 1.3 g/ml (2ml), followed by overlay of the conditioned medium (7ml). After centrifugation in a Beckman ultracentrifuge using a TL 50.2 rotor at 50,000 rpm at 14 o C for 30 h, the fractions (1ml) were removed manually from the top to avoid cross-contamination of proteins. The density was measured in each fraction by refractometry. The fractions were either lipid extracted (for 14 C-cholesterol, or 3 H-phospholipid) or counted directly ( 14 C-apoA-I) for radioactivity quantitation.
Statistical Analysis
Results are reported as mean ± standard error. Statistical significance was determined by two- Pneumocyte ABCA1 in the lung and in the cell culture system.
The presence of ABCA1 protein in the lung and isolated pneumocytes has been shown by Western blot procedures (7, 8) . In order to demonstrate the presence of ABCA1 protein in pneumocytes in the intact lung, lung sections were stained with anti-ABCA1 antibody and either the type I cell-specific antibody VIIIB2, which has been shown to recognize an epitope on rat type I cell membranes or anti-ABCA3 antibody, 3C9, which has been shown to recognize the lamellar body membrane-localized ABCA3 protein in type II cells (26, 27) . (40, 41) . Using culture conditions identical to our own, Oswari, et al (42) demonstrated that the type I-like cells lost Pro-SP-C protein and gained RTI40 reactivity, a type I cell-specific protein (43) . Fig 2 (panels a-c) demonstrates that the rat type I-like cells after 5 days of culture in 10% FCS have a flattened morphology and stain positively for ABCA1 protein as well as the VIIIB2 epitope that has been demonstrated to be specific for type I cells (26) .
Type II cells isolated from rat lungs after 24 h in culture containing ABCA3-positive lamellar bodies and ABCA1 protein are shown in Fig 2 (panels d-f) . (Fig 3 A and C) and quantitative changes in ABCA1 content obtained from densitometric analysis of blots from separate experiments expressed relative to β-actin are shown on the right (Fig 3 B, D) . After 5 days in culture with fetal calf serum, ABCA1 protein in the alveolar cells was present but at a low concentration in pneumocytes isolated from rats (Fig 3 A, time 0) and was below the level of detection in cells isolated from mice (Fig 3 C) . The transporter was up-regulated upon incubation of the type I-like alveolar cells with 9cRA/22-OH in a timedependent fashion. ABCA1 protein was elevated after 4 h in cells from both species, enhanced to a maximum after 8h (mice) or 16h (rats) of incubation, and remained robust after 24 h of exposure (Fig   3 A, B) . Previous data obtained from rat type II cells incubated under identical conditions indicated that ABCA1 protein levels peaked at 16 h and fell at 24 h (7). A direct comparison of ABCA1 protein levels in the two types of rat pneumocytes by Western analysis determined that, after 16 h of induction, the levels of ABCA1 protein in the rat type I-like alveolar cells isolated from rats were 2.5 + 0.1 -fold higher (n = 3) than levels in rat type II cells based on equal protein loading. In these experiments, the density of the ABCA1 protein band on the Western blots was expressed relative to a loading standard [ABCA1 protein in WI38VA13 human fibroblasts (44) ].
Biological activity of ABCA1
p. 15 The role of ABCA1 in the formation of nascent HDL particles depends on the interaction of apolipoprotein A-I (apoA-I) with the transporter. In order to demonstrate the presence of apoA-I in the lung, mouse lungs were perfused with PBS to remove blood, then perfused further with 4% paraformaldehyde, fixed and permeabilized. Cryosections were stained with rabbit anti-mouse apoA-I antibody. As seen in Fig 4 there was substantial respectively, over controls without additions (Fig 5) . In a series of experiments, apoA-I-mediated efflux of phospholipid under unstimulated conditions was 2.5 + 0.4 % and with up-regulation of ABCA1 was 7.0 + 1.7 % (mean + SE, n = 4, P < 0.01) while efflux of cholesterol under unstimulated or stimulated conditions was 4.3 + 0.7% or 11.8 + 1.8 % (mean + SE, n = 17, P<0.001), respectively. p. 16 ABCA1 protein levels are known to be differentially regulated depending on the cell type (45) . To explore which of the agonists was the most potent for type I-like cells, the LXR agonist, 22-OH, and the RXR agonist, 9cRA, alone or in combination, were incubated with [ 3 H]-cholesterollabeled rat type I-like cells for 16 hr followed by incubation with apoA-I for 6 or 7 hr. The LXR agonist was more effective than the RXR agonist in the up-regulation of ABCA1 protein as measured by Western blot (Fig 6, top) and by apoA-I mediated cholesterol efflux (Fig 6, bottom) . The amount of ABCA1 protein and the degree of efflux was higher upon co-incubation of the two agonists with type I-like cells (Fig 6) . The data demonstrate the direct correlation between the levels of ABCA1 and the release of cholesterol to apoA-I.
Treatment with 9cRA/22-OH induces the expression of other genes besides ABCA1.
Therefore, a known inhibitor of ABCA1 activity, Probucol, was utilized to establish the specific role of this transporter (46, 47) . Probucol inhibits ABCA1-mediated lipid efflux by inactivation of ABCA1, resulting in blockage of apoA-I binding to the cell surface (46, 47) . Probucol and efflux of cholesterol to apoA-I followed. Probucol treatment had no effect on the basal rate of cholesterol efflux that occurs in the absence of apoA-I or ABCA1 (control), but had a pronounced inhibitory effect on the release of cholesterol to apoA-I in cells exposed to 9cRA/22-OH (Fig 7) . The effect was seen at the first time point measured (2 h) and continued over the entire 7 h experiment (Fig 7A) . In three experiments, the 5-fold stimulation of cholesterol efflux due to the upregulation of ABCA1 and the presence of apoA-I was completely abolished in the presence of Probucol (Fig 7B) . These observations suggest that ABCA1 was primarily responsible for the observed apoA-I dependent lipid efflux. g/ml, the density of high density lipoprotein (Fig 8A) . Little (cells exposed to agonists alone) or no (cells exposed to no additions or apoA-I alone) cholesterol was recovered in this density range in the absence of agonists or apolipoprotein acceptor.
Formation of particles in the density
Our laboratories have shown previously that particles was isolated at a density between 1.05 and 1.21, but the composition of the particles appeared heterogeneous (Fig 8B) . Some lipid was found in the less dense fractions (density < 1.07) that contained only minor amounts of apoA-I, while apoA-I protein and lipid were associated together in the density between 1.10 and 1.20. Little material was recovered at d>1.15 where the p. 18 bulk of the BSA is found. Collectively, these data show that particles consistent with the density of nascent HDL were recovered from the media of alveolar cells incubated with apoA-I. (17) . Improved isolation protocols developed for primary cultures of type I cells will allow future studies of freshly isolated type I cells, although many primary cells loose differentiated characteristics after culture (50) .
In primary cultures of lung pneumocytes, the ABCA1 transporter in both type I-like and type II cells responded to co-incubation with 9cRA/22-OH, as was found to be the case for other primary cells in culture [human skin fibroblasts and human macrophages (35, 48) , for example] as well as various transformed cell lines including a mouse lung epithelial cell line, MLE-12 (16) . The stimulated levels of ABCA1 protein in type I-like pneumocytes were maintained for 24 h in the absence of apoA-I or other helical proteins known to stabilize the transporter and protect it from degradation (51), while ABCA1 levels in type II cells began to fall after 16 hours of exposure to agonist (7) . The regulation of ABCA1 protein levels has been shown to differ between cell types (45, 52) . In type I-like cells, the LXR agonist, 22-OH, proved to be more potent than 9cRA in stimulating both ABCA1 protein levels and biologic activity, as also was found to be the case with type II pneumocytes (data not shown). In addition, the ability of ABCA1 to stimulate apoA-I mediated lipid efflux was proportional to the levels of ABCA1 protein in both type I-like and type II cells (7) . Pneumocytes join the catalogue of cell types, such as mouse peritoneal macrophages and WI-38 fibroblasts, that release both phospholipid and cholesterol to apoA-I (53). Other cells, such as L929 fibroblasts and Chinese hamster ovary (CHO-K1) cells, release only phospholipid, while COS-7 monkey kidney cells have no ABCA1 and do not produce HDL (53) .
Several transporter proteins are stimulated by LXR/RXR agonists, some of which are involved in lipid efflux, and those that are present in the pneumocytes may have contributed to the data. However, ABCG5 and ABCG8 have not been identified in the lung, and ABCG1-mediated lipid release occurs to HDL, not apoA-I (54) (55) (56) . Notably, ABCA7 is found in the lung and mediates p. 21 apoA-I dependent lipid efflux but this ABC transporter is not sensitive to induction by LXR agonists (57) . Finally, the observed lipid efflux was completely ablated by Probucol, a compound which is known to inhibit the function of ABCA1 in the plasma membrane (46, 47) . Scavenger receptor class B type I (SR-BI) is present in type II cells, but selectively releases cholesterol to larger, phospholipidrich, HDL and is not affected by Probucol treatment (44) . Since lipid efflux was stimulated by both LXR and RXR agonists, occurred in the presence of lipid-poor apoA-I, was blocked by Probucol, and resulted in the formation of HDL-size particles, the data taken together point to the importance of ABCA1 in the lipid release process of type I-like cells. However, contributions of other proteins to lipid efflux from type I-like cells cannot be entirely ruled out.
Upon interaction of lipid-poor apoA-I with type I-like cells in culture, this study showed that particles were generated with a density consistent with that of nascent HDL. These particles contained apoA-I, cholesterol and phospholipid. Our laboratory has shown previously that the interaction of apoA-I with ABCA1 on fibroblasts and J774 macrophages in culture generates nascent discoidal HDL particles predominantly 9 and 12 nm in diameter with 2 to 4 molecules of apoA-I per particle (35, 48) . In addition, plasma membrane vesicles or microparticles are formed that lack apoA-I but contain proteins consistent with a lipid raft origin (35, 48) . Since the two types of particles formed in parallel, the findings were consistent with a concurrent release of particles from the cells and not a result of precursor-product relationships (48) . While a more detailed analysis of the particles formed by type I-like pneumocytes is necessary, the density profile and composition of the vesicles produced by type I-like cells was consistent with those found with fibroblasts and macrophages. At least two types of particles in the HDL density range were recovered from the media of the pneumocytes. The less dense particles consisted primarily of cholesterol and phospholipid with little apoA-I and the other, more dense, particles were composed of both lipids and apoA-I. Apolipoprotein E (ApoE) is another serum lipoprotein that is capable of binding lipids and Secondly, organ screening for gene expression of ABCA1 found the lung to have the second highest amount of ABCA1 mRNA, after the liver (58) . By immunohistochemical methods, this study found abundant amounts of apoA-I in the lung and significant levels of ABCA1 in type I and type II cells in both the lung and in isolated cells. Further, our current report on type I-like cells, together with our recent studies on type II cells, demonstrate that ABCA1 in both types of pneumocytes is inducible (7) . Finally, of all the organs screened in the ABCA1 gene-targeted mouse, the lung had the most predominant pathology, implicating the importance of ABCA1 function in this organ (13, 14) .
Whether or not the observed respiratory distress of the ABCA1 deficient mouse is due to affected type I cells will be of interest (14) . Thus, it is clear that all of the pathways needed for ABCA1 biological activity are available for the maintenance of lung lipid homeostasis. Recent reports have determined that the liver and intestine are important organs in the production of HDL particles, while other organ systems are felt to play an important role in the transfer of cholesterol to nascent HDL particles (59) (60) (61) . Whether the lung remodels HDL or contributes to circulating plasma HDL levels remain intriguing questions. p. 23 Due to the importance of the cholesterol and phospholipid components of surfactant lipid in maintenance of proper surface tension and viscosity, as well as the role of lipids in the maintenance of cell surface membrane integrity of pneumocytes, the lung has a need for the precise regulation of lipid turnover. Our previous and current results support the crucial role of ABCA1 in the lung in the regulation of lipid homeostasis (7, 14) . For type I-like pneumocytes, we found that ABCA1 protein levels were inducible through exposure to LXR/RXR agonists. Incubation with apoA-I, the major apolipoprotein component of HDL, resulted in the ABCA1-mediated production of heterogeneous particles that isolate in the density range of HDL. The present findings add type I-like pneumocytes to the inventory of extra-hepatic, non-macrophage cells capable of the assembly of HDL with exogenous apoA-I. The subsequent fates of these newly produced lipoprotein particles, whether they reach the circulation and/or add to plasma HDL levels, remain to be determined. Should these observations with type I-like cells in culture be substantiated by type I cells in vivo, the ability to assemble particles comparable to nascent HDL will add to the growing list of physiologic functions attributable to type I cells, pneumocytes which were once thought to serve only as an inert barrier between the circulation and the air space in the lung. 
